Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer’s in Trials. Biogen Jumps. Novo Nordisk stock fell sharply Monday after the Danish pharmaceutical company announced that Ozempic didn’t slow the progression of Alzheimer’s disease.

The prospect of an interest-rate cut typically boosts the stock market, since the promise of cheaper borrowing means a potential boon for firms and their investors. But the opposite also holds true, analysts said: As hope of a rate cut fades, stocks may turn lower.

The stock is falling despite the company reporting revenue growth of over 100% in its most recently completed quarter.

Chipmakers including Nvidia and Intel are down along with much of the stock market Tuesday, as fears of an AI bubble grow.

London's FTSE 100 slipped for the fifth consecutive session on Wednesday with defence and financial stocks leading the downturn, while inflation data bolstered expectations for a December interest rate reduction.

Shares of Semiconductor Manufacturing International Corp., China's largest contract chip maker and the only one capable of making advanced chips, dropped as much as 7.4% early Monday before paring some losses. China's No.2 foundry, Hua Hong Semiconductor, declined 6.2%, while ASMPT was down 2.1%.

Warren Buffett has built his legendary investment success by embracing market crashes rather than fearing them. Learn his time-tested strategies for turning market panic into profits.

As of Nov. 24, 2025, two stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.